Skip to content

EMG-biofeedback in muscular dystrophy

The comparison of effectiveness of strengthening exercises with and without EMG-biofeedback on function in patients with muscular dystrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200326046864N1
Enrollment
40
Registered
2020-04-19
Start date
2020-06-21
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscular dystrophy. G71.00 - Muscular dystrophy, unspecified

Interventions

Intervention 1: Intervention group: strengthening exercises using EMG-biofeedback. EMG biofeedback is a method of retraining muscle by creating new feedback systems as a result of the conversion of

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Muscular dystrophy with proximal muscles involvement Approved muscular dystrophy diagnosis by neurologist Ability to walk 10 meters without help To be volunteer for intervention

Exclusion criteria

Exclusion criteria: Using drugs affecting muscular strength Acute myositis Orthopedic problems limiting patient movements Other neurologic or systemic disease involving muscles Skin lesion or infection at the site of electrode placements History of symptomatic cardiomyopathy

Design outcomes

Primary

MeasureTime frame
Muscle strength. Timepoint: before intervention, after 6 weeks intervention, 3 months post intervention. Method of measurement: dynamometer.

Secondary

MeasureTime frame
Motor Function. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: The Motor Function Measure-32 scale.;Fatigue severity. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Fatigue severity scale.;Balance. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: Berg Balance Scale.;Quality of life. Timepoint: before, 6 weeks and 3 months post intervention. Method of measurement: SF-36 for quality of life evaluation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNastaran Maghbouli

Tehran University of Medical Sciences

nasi_lam@yahoo.com+98 21 8490 2110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026